Bevacizumab Plus Gemcitabine, Docetaxel, Melphalan, and Carboplatin in Ovarian Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE1
An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients
- Status
- TERMINATED
- Phase
- PHASE3
Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2